Pulmonary Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB [Phase 2]
A Phase 2 trial comparing VentaProst to conventionally-administered aerosolized epoprostenol in patients with pulmonary hypertension undergo…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH) [Phase 2]
Phase 2 trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of BAY63-2521 in patients with inters…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Quality of Life Assessed With the PAH SYMPACT Questionnaire
The clinical trial update summarizes quality-of-life findings in pulmonary hypertension using the PAH SYMPACT questionnaire.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents [NA]
Clinical trial update evaluating inhalational and intravenous therapies for pulmonary hypertension in high-risk cardiac surgery patients. Th…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Evaluation of the Usefulness of Adopting Remote, Mobile-based 6MWT Among Hospital Outpatients (the 6-APPnow), Within the Constraints Imposed by the SARS-COV2 Pandemic
A completed trial evaluated the usefulness of adopting remote, mobile-based 6-minute walk tests for hospital outpatients during the COVID-19…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Melatonin for Pulmonary Hypertension in Full Term Neonates [Phase 3]
Phase 3 trial evaluating melatonin for pulmonary hypertension in full-term neonates has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Non-Invasive Lung Water Monitoring in Pulmonary Hypertension
This clinical trial update notes the completion of a study evaluating non-invasive lung water monitoring in patients with pulmonary hyperten…
-
CLINICAL_TRIALS trial_result · 2025-04-21Clinical Trial Update: Exercise Training to Improve Cardiopulmonary Hemodynamics in Heart Failure Patients [NA]
A Mayo Clinic-sponsored clinical trial evaluating exercise training to improve cardiopulmonary hemodynamics in heart failure patients with p…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: A Study for the Identification of Biomarker Signatures for Diagnosis of Pulmonary Hypertension (PH) in Participants at Low or Intermediate Probability of PH Undergoing Cardiac Magnetic Resonance Imaging [EARLY_Phase 1]
This EARLY Phase 1 clinical trial update reports completion of a study to identify biomarker signatures for diagnosing pulmonary hypertensio…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease [Phase 2]
A Phase 2 study evaluating the safety and tolerability of Treprostinil Palmitil Inhalation Powder in participants with Pulmonary Hypertensio…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Copd Exacerbation and Pulmonary Hypertension Trial [Phase 4]
Phase 4 clinical trial evaluating COPD exacerbation with pulmonary hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Metformin for Pulmonary Hypertension HFpEF [Phase 2]
A Phase 2 clinical trial sponsored by the University of California, San Francisco is evaluating metformin for pulmonary hypertension in pati…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Evaluation of a New 6 Minute Walk Test Smartphone App in Patients With Pulmonary Hypertension
Clinical trial completion and results posting for a new smartphone app used to perform the 6-minute walk test in patients with pulmonary hyp…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension [NA]
Clinical trial update for the Gradient Denervation System for pulmonary artery denervation in heart failure patients with pulmonary hyperten…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007) [Phase 2, Phase 3]
A Phase 2/3 study (INSIGNIA-PAH) evaluated the inhaled sGC stimulator Frespaciguat (MK-5475) for pulmonary arterial hypertension; the trial …
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart Failure
This clinical trial update describes the characteristics and outcomes of patients with pulmonary hypertension-associated right heart failure…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial comparing inhaled milrinone versus intravenous milrinone in patients undergoing mitral valve replacement s…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH) [Phase 3]
Phase 3 trial evaluating Bosentan in sickle cell disease patients with pulmonary hypertension was terminated, with the update focusing on ef…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects [Phase 1]
Vicore Pharma AB's first-in-human Phase 1 study of C106 in healthy subjects assessed safety, tolerability, and pharmacokinetics; results hav…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension [Phase 2, Phase 3]
A Phase 2/3 clinical trial of Angiogenic Cell Therapy for progressive pulmonary hypertension has been terminated, and results have been post…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Cognitive Behavioral Therapy and Light Therapy [NA]
University of Pennsylvania completed a clinical trial evaluating cognitive-behavioral therapy and light therapy for insomnia and fatigue in …
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating inhaled nitric oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia was terminated. Results we…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Pediatric Ventricle Function Assessment Study
A pediatric clinical trial evaluating right and left ventricular function has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension [Phase 2]
A Phase 2 clinical trial evaluating tamoxifen therapy for pulmonary arterial hypertension has completed, with results posted in December 202…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: PIMR and Pulmonary Vascular Disease
The UCLA-sponsored trial on PIMR for pulmonary hypertension has completed. The snippet only notes the status and does not provide results.